• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A case of POEMS syndrome presenting craniocervical vascular stenosis].

作者信息

Sawada Minori, Okumura Gaku, Takasone Ken, Katoh Nagaaki, Sekijima Yoshiki

机构信息

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine.

出版信息

Rinsho Shinkeigaku. 2025 Jul 25;65(7):511-515. doi: 10.5692/clinicalneurol.cn-002064. Epub 2025 Jun 21.

DOI:10.5692/clinicalneurol.cn-002064
PMID:40545351
Abstract

A 54-years-old Japanese man visited local hospital with six-month history of progressive numbness and muscle weakness in his lower limbs. He was diagnosed with POEMS syndrome based on positive serum M-protein, elevated serum VEGF, and splenomegaly. MRI showed multiple cerebral infarcts in the watershed area, and MRA showed complete vascular occlusion of the right internal carotid artery and severe vascular stenosis of the left common carotid artery, suggesting hemodynamic cerebral infarction. He was referred to our department and treated with three courses of Daratumumab-Bortezomib-Dexamethasone (DBd) therapy. After normalization of VEGF was confirmed, right superficial temporal artery-middle cerebral bypass surgery was performed. He has been kept in good condition with improved muscle strength and walking ability, and normalized VEGF level under the maintenance Daratumumab-Lenalidomide-Dexamethasone (DLd) therapy. Because POEMS syndrome-associated vasculopathy can develop even in the very early stage of the disease, intensive evaluation of craniocervical vessels before treatment initiation is very important for treatment selection and risk assessment.

摘要

相似文献

1
[A case of POEMS syndrome presenting craniocervical vascular stenosis].
Rinsho Shinkeigaku. 2025 Jul 25;65(7):511-515. doi: 10.5692/clinicalneurol.cn-002064. Epub 2025 Jun 21.
2
Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review.在颈动脉狭窄中,双功超声和磁共振血管造影与数字减影血管造影的比较:一项系统评价。
Stroke. 2003 May;34(5):1324-32. doi: 10.1161/01.STR.0000068367.08991.A2. Epub 2003 Apr 10.
3
Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments.双功能超声用于诊断颅外段有症状颈动脉狭窄。
Cochrane Database Syst Rev. 2022 Jul 11;7(7):CD013172. doi: 10.1002/14651858.CD013172.pub2.
4
Delayed Diagnosis of Poems Syndrome, How AI Tools Can Enhance Diagnostic Accuracy.POEMS综合征的延迟诊断,人工智能工具如何提高诊断准确性。
Eur J Case Rep Intern Med. 2025 Jun 5;12(7):005504. doi: 10.12890/2025_005504. eCollection 2025.
5
Unicentric Castleman disease following POEMS syndrome remission.POEMS综合征缓解后出现的单中心Castleman病。
J Hematop. 2025 Jul 10;18(1):31. doi: 10.1007/s12308-025-00646-6.
6
Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial.isatuximab、硼替佐米、来那度胺与小剂量地塞米松用于不适宜移植的多发性骨髓瘤患者(REST):一项多中心、单臂、2期试验
Lancet Haematol. 2025 Feb;12(2):e120-e127. doi: 10.1016/S2352-3026(24)00347-8.
7
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.硼替佐米、沙利度胺和地塞米松联合或不联合达雷妥尤单抗,随后进行达雷妥尤单抗维持或观察治疗,适用于适合移植的新诊断多发性骨髓瘤:CASSIOPEIA 随机对照 3 期试验的长期随访。
Lancet Oncol. 2024 Aug;25(8):1003-1014. doi: 10.1016/S1470-2045(24)00282-1. Epub 2024 Jun 15.
8
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.达雷妥尤单抗、硼替佐米、来那度胺和地塞米松治疗多发性骨髓瘤。
N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12.
9
Treatment Outcomes in Patients With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem-Cell Transplantation: Systematic Review and Network Meta-analysis.不适合干细胞移植的新诊断多发性骨髓瘤患者的治疗结局:系统评价和网络荟萃分析。
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e478-e488. doi: 10.1016/j.clml.2019.04.009. Epub 2019 Apr 29.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.